Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mechanisms controlling CDK9 activity.

Renee M Marshall1, Xavier Grana

  • 1Fels Institute for Cancer Research and Molecular Biology, Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA.

Frontiers in Bioscience : a Journal and Virtual Library
|May 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editors' Corner: Suppressor of cytokine signaling 6 (SOCS6) mediates ubiquitination-dependent degradation of SLC7A11 to promote ferroptosis in ovarian cancer.

Gene·2025
Same author

Derivation of human primary prostate epithelial cell lines by differentially targeting the CDKN2A locus along with expression of hTERT.

Scientific reports·2024
Same author

FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs.

Nature communications·2024
Same author

Derivation of human primary prostate epithelial cell lines by differentially targeting the <i>CDKN2A</i> locus along with expression of hTERT.

Research square·2024
Same author

Autophagy Contributes to Homeostasis in Esophageal Epithelium Where High Autophagic Vesicle Level Marks Basal Cells With Limited Proliferation and Enhanced Self-Renewal Potential.

Cellular and molecular gastroenterology and hepatology·2024
Same author

4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress.

Molecular cancer therapeutics·2023

This review explores Cyclin-Dependent Kinase 9 (CDK9) and its role in gene transcription. It highlights CDK9

Area of Science:

  • Molecular Biology
  • Gene Regulation
  • Biochemistry

Background:

  • Cyclin-Dependent Kinase 9 (CDK9) is a key regulator of gene transcription.
  • CDK9 forms positive transcription elongation factor complexes (P-TEFb) with cyclins T1, T2a, T2b, and K.
  • P-TEFb is crucial for stimulating the elongation of paused RNA polymerase II (RNAPII) transcripts.

Purpose of the Study:

  • To review the mechanisms modulating CDK9 activity and its gene recruitment.
  • To discuss the role of CDK9 in transcription and disease pathogenesis.
  • To explore the therapeutic potential of targeting CDK9.

Main Methods:

  • Literature review of research on CDK9 function and regulation.
  • Analysis of studies investigating P-TEFb's role in RNAPII phosphorylation.

Related Experiment Videos

  • Examination of disease-associated CDK9 dysregulation, including HIV-1 replication and cardiac hypertrophy.

    • Main Results:

    • CDK9 phosphorylates the C-terminal domain of RNAPII and negative elongation factors.
    • P-TEFb enhances RNAPII transcript elongation and influences other transcription steps.
    • Aberrant CDK9 activity is implicated in HIV-1 replication and cardiac hypertrophy.

    Conclusions:

    • CDK9 is a critical regulator of gene transcription with broader roles beyond elongation.
    • Dysfunctional CDK9 is linked to significant human diseases.
    • Targeting CDK9 presents a potential therapeutic strategy for diseases like HIV-1 infection and cardiac hypertrophy.